#antiCD20therapy

FDA kicks off review of Roche's Gazyva for wider lupus use Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus erythematosus.

#Roche could be just months away from an FDA approval of #Gazyva as the first #antiCD20therapy for #systemiclupuserythematosus (SLE), a debilitating #autoimmune disease affecting millions of people around the world.